Brown Brothers Harriman & Co’s LeMaitre Vascular LMAT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.77K	Hold	81	–	–	﹤0.01%	1471
2026 Q1	$8.84K	Buy	81 +79	+3,950%	+$7.53K	﹤0.01%	1377
2025 Q4	$162	Sell	2 -81	-98%	-$6.97K	﹤0.01%	1819
2025 Q3	$7.26K	Buy	+83	New	+$7.41K	﹤0.01%	1335
2025 Q2	–	Sell	-67	Closed	-$5.62K	–	1595
2025 Q1	$5.62K	Hold	67	–	–	﹤0.01%	1141
2024 Q4	$6.17K	Hold	67	–	–	﹤0.01%	1202
2024 Q3	$6.22K	Buy	+67	New	+$5.8K	﹤0.01%	1127
2016 Q1	–	Sell	-110,916	Closed	-$1.91M	–	708
2015 Q4	$1.91M	Hold	110,916	–	–	0.01%	145
2015 Q3	$1.35M	Buy	110,916 +59,647	+116%	+$765K	0.01%	168
2015 Q2	$618K	Buy	51,269 +1,047	+2%	+$10.3K	﹤0.01%	231
2015 Q1	$421K	Hold	50,222	–	–	﹤0.01%	276
2014 Q4	$384K	Hold	50,222	–	–	﹤0.01%	290
2014 Q3	$346K	Hold	50,222	–	–	﹤0.01%	302
2014 Q2	$415K	Buy	50,222 +5,225	+12%	+$40.8K	﹤0.01%	278
2014 Q1	$363K	Sell	44,997 -44,997	-50%	-$360K	﹤0.01%	277
2013 Q4	$720K	Buy	89,994 +44,997	+100%	+$348K	﹤0.01%	275
2013 Q3	$301K	Hold	44,997	–	–	﹤0.01%	283
2013 Q2	$294K	Buy	+44,997	New	+$284K	﹤0.01%	344

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Brown Brothers Harriman & Co's LMAT Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 81 shares worth $7.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Brown Brothers Harriman & Co first reported a position in LMAT in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.91M in Q4 2015. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Brown Brothers Harriman & Co held 81 shares of LeMaitre Vascular worth $7.77K as of Q2 2026.
Brown Brothers Harriman & Co left its LeMaitre Vascular share count unchanged in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1471 holding.
Brown Brothers Harriman & Co first reported a position in LeMaitre Vascular in Q2 2013 and has held it in 18 quarters since.
Brown Brothers Harriman & Co's LeMaitre Vascular position peaked at $1.91M in Q4 2015.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.